Nektar Therapeutics (NKTR) Insider Trading
- $1,135,850.00
- $232,733,149.01
- May 19, 2025
- Howard W Robin
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| July 14, 2015 | SVP | 33,334 | $11.78 | Sell | $392,674.52 | |
| July 14, 2015 | CEO | 58,334 | $11.78 | Sell | $687,174.52 | |
| June 29, 2015 | Director | 30,000 | $12.70 | Sell | $381,000.00 | |
| June 19, 2015 | Director | 15,000 | $11.81 | Sell | $177,150.00 | |
| June 15, 2015 | Director | 25,000 | $11.15 | Sell | $278,750.00 | |
| Dec. 29, 2014 | Director | 29,500 | $15.34 | Sell | $452,530.00 | |
| Dec. 22, 2014 | CAO | 5,000 | $15.56 | Sell | $77,800.00 | |
| Dec. 1, 2014 | CEO | 350,000 | $17.01 | Sell | $5,953,500.00 | |
| Dec. 1, 2014 | SVP | 120,000 | $17.02 | Sell | $2,042,400.00 | |
| Nov. 25, 2014 | CEO | 600,000 | $15.25 | Sell | $9,150,000.00 | |
| Nov. 24, 2014 | Director | 15,000 | $15.02 | Sell | $225,300.00 | |
| Nov. 24, 2014 | SVP | 10,500 | $15.04 | Sell | $157,920.00 | |
| Nov. 24, 2014 | CEO | 132,800 | $15.02 | Sell | $1,994,656.00 | |
| Nov. 3, 2014 | SVP | 9,900 | $13.78 | Sell | $136,422.00 | |
| Aug. 5, 2013 | Director | 12,500 | $12.41 | Sell | $155,125.00 | |
| Sept. 14, 2012 | Director | 5,000 | $9.18 | Buy | $45,900.00 |
Insiders are both buying and selling Nektar Therapeutics stock.
The insider traders at Nektar Therapeutics are: Howard W Robin, Gil M. Labrucherie, Jillian B. Thomsen, Jonathan Zalevsky, Robert Chess, John Nicholson, Howard W. Robin, Gil M Labrucherie, Stephen K Doberstein, Jillian B Thomsen, Mark Andrew Wilson, Lutz Lingnau, Ivan P Gergel, Maninder Hora, Jeffrey Robert Ajer, R Scott Greer, Dennis L Winger, Christopher A Kuebler, Myriam Curet, Susan Wang, Christopher A. Kuebler, Roy A Whitfield, Karin Eastham, Curet Myriam, Roy Whitfield, John Northcott, Deep Track Capital, Lp, Stephen K. Doberstein, and Katharina Otto-Bernstein
The most active insider trader at Nektar Therapeutics is Howard W Robin with 52 trades.
Howard W Robin has sold the most Nektar Therapeutics stock with a total value of $84,372,374.91.
Roy A Whitfield has bought the most Nektar Therapeutics stock with a total value of $1,256,500.00.
The most recent insider trade for Nektar Therapeutics was on May 19, 2025.
The single biggest insider buy for Nektar Therapeutics was from Roy A Whitfield with a total value of $628,250.00 on Aug. 10, 2017.
The single biggest insider sell for Nektar Therapeutics was from John Nicholson with a total value of $21,853,694.88 on March 7, 2018.